"Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Preliminary injunctions in pharmaceutical patent cases in Japan"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Regimen patents: LCM failures and successes"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Generic should sue the Minister of Health, Labour and Welfare instead of filing a DJ action, says IP High Court"

• Newsletter
• IP Disputes
• Life Science and Health Care

"DOE and cross-border infringement of a biologics process patent"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Comparative analysis of demonstratives in patent litigation"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications
• International Disputes

"Trade secrets in Japan: Oral information disclosure from memory"

• Newsletter
• IP Disputes

"Japan’s Supreme Court gives first ruling on a Criminal Trade Secret Infringement"

• Newsletter
• IP Disputes

"METI’s ‘Good Faith Negotiation Guidelines for Standard Essential Patent Licenses’"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"The Japan Patent Office’s ‘Guide to Licensing Negotiations Involving Standard Essential Patents’ (second edition)"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"Antimonopoly Act defence unsuccessful against patent enforcement"

• Newsletter
• IP Disputes
• Antitrust/Competition

"Overseas knockdown production and patent infringement"

• Newsletter
• IP Disputes
• IT and Telecommunications
• Cross-Border Transactions

"FRAND declared SEPs and a warning letter"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"SEPs and the automotive industry in Japan"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"Japan Supreme Court acquits defendant in Coinhive case"

• Newsletter
• IT and Telecommunications

"Directors’ liability for patent infringement pursuant to the Companies Act"

• Newsletter
• IP Disputes
• General Corporate
• Restructuring and Insolvency

"A new drug pricing system reform proposal in Japan"

• Newsletter
• Life Science and Health Care

"Assessing the licensing environment of SEPs in Japan"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"Clinical trials for original drugs fall under experimental use exception"

• Newsletter
• IP Disputes
• Life Science and Health Care

"A closer look at Japan’s desirable patent system in the era of COVID-19"

• Newsletter
• IP Disputes
• IP Transactions
• Life Science and Health Care
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions

"The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"U.S. Patent Litigation Update : The Resurgence of Patent Trolls"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications
• International Disputes

"Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"Damages awarded based on LED-equipped TV for LED patent infringement"

• Newsletter
• IP Disputes

"Courts rule on likelihood of confusion in medical device case"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Antimonopoly Act defence proves successful against patent enforcement"

• Newsletter
• IP Disputes
• Antitrust/Competition

"Rituximab biosimilar patent infringement lawsuit"

• Newsletter
• IP Disputes
• Life Science and Health Care

"The Broad Institute’s CRISPR-Cas9 patents"

• Newsletter
• IP Disputes
• Life Science and Health Care

"How was Japanese patent litigation reformed"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications

"Inventor of anti-PD-L1 antibody patent"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Fair value calculation of SEPs for multi-component products"

• Newsletter
• IP Disputes
• IP Transactions
• IT and Telecommunications
• International Disputes
• Cross-Border Transactions
• Antitrust/Competition

"New IP Mediation Proceedings"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications

"Refunding your deposit in a foreign bank"

• Newsletter
• Cross-Border Transactions

"Antibodies: Should they be defined by function or sequence?"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Japan suffers from trade secret infringement"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications

"Depriving others of their intellectual property"

• Newsletter
• IP Disputes
• IP Transactions
• Life Science and Health Care
• IT and Telecommunications
• Cross-Border Transactions
• Antitrust/Competition

"Struggle of Gods on unexpected and remarkable effect"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Inspectoin System: Sacred Sword or Rusty Sword?"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications

"JFTC's attitude towards Reverse Payment"

• Newsletter
• IP Disputes
• Life Science and Health Care
• Antitrust/Competition

"Analyzing the first generic drug cartel case"

• Newsletter
• IP Disputes
• Life Science and Health Care
• Antitrust/Competition

"IP High Court finds free riding and dilution by GUZZILLA trademark"

• Newsletter
• IP Disputes

"Court addresses foreign clinical trial periods and patent term extension"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Analysing the PD-1 antibody patent litigation"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Examining the first biosimilar patent litigation"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Examining proposed amendments to evidence collection procedures"

• Newsletter
• IP Disputes
• Life Science and Health Care
• IT and Telecommunications

"IP High Court affirms validity of crestor patent"

• Newsletter
• IP Disputes
• Life Science and Health Care

"Patent infringement when a product changes after manufacturing"

• Newsletter
• IP Disputes

"Points in M&A legal due diligence where a target company has overseas subsidiaries"

• Newsletter
• M&A

"First preliminary injunction in a store appearance case"

• Newsletter
• IP Disputes

"Claim interpretation in 3D TV patent infringement case"

• Newsletter
• IP Disputes